These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 22383169)

  • 21. High frequency of MYC gene amplification is a common feature of radiation-induced sarcomas. Further results from EORTC STBSG TL 01/01.
    Käcker C; Marx A; Mössinger K; Svehla F; Schneider U; Hogendoorn PC; Nielsen OS; Küffer S; Sauer C; Fisher C; Hallermann C; Hartmann JT; Blay JY; Mechtersheimer G; Hohenberger P; Ströbel P
    Genes Chromosomes Cancer; 2013 Jan; 52(1):93-8. PubMed ID: 23012233
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Key roles for MYC, KIT and RET signaling in secondary angiosarcomas.
    Styring E; Seinen J; Dominguez-Valentin M; Domanski HA; Jönsson M; von Steyern FV; Hoekstra HJ; Suurmeijer AJ; Nilbert M
    Br J Cancer; 2014 Jul; 111(2):407-12. PubMed ID: 24983371
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Silencing of thrombospondin-1 is critical for myc-induced metastatic phenotypes in medulloblastoma.
    Zhou L; Picard D; Ra YS; Li M; Northcott PA; Hu Y; Stearns D; Hawkins C; Taylor MD; Rutka J; Der SD; Huang A
    Cancer Res; 2010 Oct; 70(20):8199-210. PubMed ID: 20876797
    [TBL] [Abstract][Full Text] [Related]  

  • 24. MYC amplification and polysomy 8 in chondrosarcoma: array comparative genomic hybridization, fluorescent in situ hybridization, and association with outcome.
    Morrison C; Radmacher M; Mohammed N; Suster D; Auer H; Jones S; Riggenbach J; Kelbick N; Bos G; Mayerson J
    J Clin Oncol; 2005 Dec; 23(36):9369-76. PubMed ID: 16361637
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Co-amplification and concomitant high levels of expression of a DEAD box gene with MYCN in human neuroblastoma.
    Manohar CF; Salwen HR; Brodeur GM; Cohn SL
    Genes Chromosomes Cancer; 1995 Nov; 14(3):196-203. PubMed ID: 8589036
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Combined microarray analysis of small cell lung cancer reveals altered apoptotic balance and distinct expression signatures of MYC family gene amplification.
    Kim YH; Girard L; Giacomini CP; Wang P; Hernandez-Boussard T; Tibshirani R; Minna JD; Pollack JR
    Oncogene; 2006 Jan; 25(1):130-8. PubMed ID: 16116477
    [TBL] [Abstract][Full Text] [Related]  

  • 27. 8q24 amplification is associated with Myc expression and prostate cancer progression and is an independent predictor of recurrence after radical prostatectomy.
    Fromont G; Godet J; Peyret A; Irani J; Celhay O; Rozet F; Cathelineau X; Cussenot O
    Hum Pathol; 2013 Aug; 44(8):1617-23. PubMed ID: 23574779
    [TBL] [Abstract][Full Text] [Related]  

  • 28. c-MYC amplification and c-myc protein expression in pancreatic acinar cell carcinomas. New insights into the molecular signature of these rare cancers.
    La Rosa S; Bernasconi B; Vanoli A; Sciarra A; Notohara K; Albarello L; Casnedi S; Billo P; Zhang L; Tibiletti MG; Sessa F
    Virchows Arch; 2018 Oct; 473(4):435-441. PubMed ID: 29721608
    [TBL] [Abstract][Full Text] [Related]  

  • 29. MiR-17-92 cluster is associated with 13q gain and c-myc expression during colorectal adenoma to adenocarcinoma progression.
    Diosdado B; van de Wiel MA; Terhaar Sive Droste JS; Mongera S; Postma C; Meijerink WJ; Carvalho B; Meijer GA
    Br J Cancer; 2009 Aug; 101(4):707-14. PubMed ID: 19672269
    [TBL] [Abstract][Full Text] [Related]  

  • 30. ID2 expression is not associated with MYCN amplification or expression in human neuroblastomas.
    Wang Q; Hii G; Shusterman S; Mosse Y; Winter CL; Guo C; Zhao H; Rappaport E; Hogarty MD; Maris JM
    Cancer Res; 2003 Apr; 63(7):1631-5. PubMed ID: 12670915
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The utility of MYC and FLT4 in the diagnosis and treatment of postradiation atypical vascular lesion and angiosarcoma of the breast.
    Cornejo KM; Deng A; Wu H; Cosar EF; Khan A; St Cyr M; Tomaszewicz K; Dresser K; O'Donnell P; Hutchinson L
    Hum Pathol; 2015 Jun; 46(6):868-75. PubMed ID: 25864386
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Amplification of c-myc by fluorescence in situ hybridization in a population-based breast cancer tissue array.
    Rummukainen JK; Salminen T; Lundin J; Kytölä S; Joensuu H; Isola JJ
    Mod Pathol; 2001 Oct; 14(10):1030-5. PubMed ID: 11598174
    [TBL] [Abstract][Full Text] [Related]  

  • 33. c-myc and chromosome 8 centromere studies of ovarian cancer by interphase FISH.
    Wang ZR; Liu W; Smith ST; Parrish RS; Young SR
    Exp Mol Pathol; 1999 Jun; 66(2):140-8. PubMed ID: 10409442
    [TBL] [Abstract][Full Text] [Related]  

  • 34. MET gene copy number alterations and expression of MET and hepatocyte growth factor are potential biomarkers in angiosarcomas and undifferentiated pleomorphic sarcomas.
    Schmitz K; Koeppen H; Binot E; Fassunke J; Künstlinger H; Ihle MA; Heydt C; Wardelmann E; Büttner R; Merkelbach-Bruse S; Rüschoff J; Schildhaus HU
    PLoS One; 2015; 10(4):e0120079. PubMed ID: 25844809
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Amplification of c-myc, K-sam, and c-met in gastric cancers: detection by fluorescence in situ hybridization.
    Hara T; Ooi A; Kobayashi M; Mai M; Yanagihara K; Nakanishi I
    Lab Invest; 1998 Sep; 78(9):1143-53. PubMed ID: 9759658
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Amplification and overexpression of the L-MYC proto-oncogene in ovarian carcinomas.
    Wu R; Lin L; Beer DG; Ellenson LH; Lamb BJ; Rouillard JM; Kuick R; Hanash S; Schwartz DR; Fearon ER; Cho KR
    Am J Pathol; 2003 May; 162(5):1603-10. PubMed ID: 12707044
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Tumor-suppressive microRNA-22 inhibits the transcription of E-box-containing c-Myc target genes by silencing c-Myc binding protein.
    Xiong J; Du Q; Liang Z
    Oncogene; 2010 Sep; 29(35):4980-8. PubMed ID: 20562918
    [TBL] [Abstract][Full Text] [Related]  

  • 38. MYC is activated by USP2a-mediated modulation of microRNAs in prostate cancer.
    Benassi B; Flavin R; Marchionni L; Zanata S; Pan Y; Chowdhury D; Marani M; Strano S; Muti P; Blandino G; Loda M
    Cancer Discov; 2012 Mar; 2(3):236-47. PubMed ID: 22585994
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Synergism of c-myc and p16 in oral squamous cell carcinoma].
    Liu NG; Shan CM; Wu SH; Lu ZH; Kang GY
    Ai Zheng; 2004 Jun; 23(6):635-9. PubMed ID: 15191661
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Augmentation of tumor angiogenesis by a Myc-activated microRNA cluster.
    Dews M; Homayouni A; Yu D; Murphy D; Sevignani C; Wentzel E; Furth EE; Lee WM; Enders GH; Mendell JT; Thomas-Tikhonenko A
    Nat Genet; 2006 Sep; 38(9):1060-5. PubMed ID: 16878133
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.